Mac Leckrone, president of
Alliacense, said: "As the First Round MMP licensing berths in many industry
sectors are being captured, royalty rates are increasing according to
plan." Pohl noted that Patriot Scientific is unable to reveal the exact
dollar amount of the Lexmark transaction due to contractual confidentiality
obligations as well as the sensitivity of ongoing negotiations with other
potential licensees.